 |
The BeatAuthor: HLTH
The Beat, powered by HLTH, is a weekly interview series dedicated to paving a better path forward for the future of health. Each week a variety of hosts bring you authentic conversations with prominent thought leaders. Through these interviews with people at the forefront of change in healthcare, we hope to spark new ideas and encourage new collaborations among listeners. Language: en Genres: Health & Fitness, Medicine, Mental Health Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Smarter Diagnostics: Dr. Julie Schulz on Turning Lab Testing into a Strategic Advantage for Value-Based Care
Episode 340
Tuesday, 11 November, 2025
About Dr. Julie Schulz:Dr. Julie Schulz, MD, MPH, is a physician executive and product leader based in Los Angeles with a proven track record of driving innovation at the intersection of healthcare, technology, and business. Over the past 15 years, she has built and led teams developing healthcare decision support, analytics, and consumer health products across value-based care, women’s health, and life sciences. As VP of Product at Avalon Healthcare Solutions, she leads strategy for next-generation diagnostics platforms. Previously, at HALO Diagnostics and Doctor Evidence, she guided product and business development efforts that integrated imaging, laboratory, and evidence-based analytics to improve patient and physician experiences. Earlier roles at Lumere and Sg2 honed her expertise in clinical data, product-market fit, and scaling evidence-driven solutions. Published in leading journals, Dr. Schulz combines deep clinical insight with strategic leadership to advance innovations that improve healthcare outcomes and drive measurable business impact.Things You’ll Learn:Diagnostic intelligence can transform diagnostics from a cost center into a strategic asset that improves quality and lowers costs.Physicians face overwhelming volumes of new tests and guidelines, and AI-powered decision support can ease their cognitive burden.By removing prior authorization barriers, patients can transition from diagnosis to treatment in just 15 days, rather than the typical 60 days.Data shows that healthier patients are more likely to receive GLP-1 prescriptions, revealing a need for better risk-adjusted care strategies.True innovation in healthcare depends on communication, simplifying complexity and aligning clinicians, payers, and technologists toward shared goals.Resources:Connect with and follow Dr. Julie Schulz on LinkedIn.Follow Avalon Healthcare Solutions on LinkedIn and explore their website.Read Avalon Healthcare Solutions’ Annual Lab Trend Report here.
